Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: A model for Duchenne muscular dystrophy

Cell

Volumn 90, Issue 4, 1997, Pages 729-738

  Grady, R Mark ^a   Teng, Haibing ^a   Nichol, Mia C ^a   Cunningham, Jeanette C ^a   Wilkinson, Robert S ^a   Sanest, Joshua R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; DYSTROPHIN; UTROPHIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; HEART MUSCLE CELL; MOUSE; MUSCLE ATROPHY; MYOPATHY; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SKELETAL MUSCLE;

ANIMALIA;

EID: 0030848338     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80533-4     Document Type: Article

References (63)

1. Ahn, A.H., and Kunkel, L.M. (1993). The structural and functional diversity of dystrophin. Nature Genet. 3, 283-291.
2. Amalfitano, A.,and Chamberlain, J.S. (1996). The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele. Muscle Nerve 19, 1549-1553.
3. Apel, E.D., Roberds, S.L., Campbell, K.P., and Merlie, J.P. (1995). Rapsyn may function as a link between the acetylcholine receptor and agrin-binding dystrophin-associated glycoprotein complex. Neuron 15, 115-126.
4. Bell, C.D., and Conen, P.E. (1968). Histopathological changes in Duchenne muscular dystrophy. J. Neurol. Sci. 7, 529-544.
5. Blake, D.J., Tinsley, J.M., and Davies, K.E. (1996). Utrophin: a structural and functional comparison to dystrophin. Brain Pathol. 6, 37-47.
6. Bowe, M.A., Deyst, K.A., Leszyk, J.D., and Fallon, J.R. (1994). Identification and purification of an agrin receptor from Torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans. Neuron 12, 1173-1180.
7. Bridges, L.R. (1986). The association of cardiac muscle necrosis and inflammation with the degenerative and persistent myopathy of MDX mice. J. Neurol. Sci. 72, 147-157.
8. Bulfield, G., Siller, W.G., Wight, P.A.L., and Moore, K.J. (1984). X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81, 1189-1192.
9. Campanelli, J.T., Roberds, S.L., Campbell, K.P., and Scheller, R.H. (1994). A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell 77, 663-674.
10. Campbell, K.P. (1995). Molecular basis of three muscular dystrophies: disruption of cytoskeleton-extracellular matrix linkage. Cell 80, 675-679.
11. Carlson, B.M. and Faulkner, J.A. (1983). The regeneration of skeletal muscle fibers following injury: a review. Med. Sci. Sports Exerc. 15, 187-198.
12. Carnwath, J.W. and Shotton, D.M. (1987). Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J. Neurol. Sci. 80, 39-54.
13. Close, R.I. (1972). Dynamic properties of mammalian skeletal muscles. Physiol. Rev. 52, 129-197.
14. Coulton, G.R., Morgan, J.E., Partridge, T.A., and Sloper, J.C. (1988). The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol. Appl. Neurobiol. 14, 53-70.
15. Cox, G.A., Cole, N.M., Matsumura, K., Phelps, S.F., Hauschka, S.D., Campbell, K.P., Faulkner, J.A., and Chamberlain, J.S. (1993). Over-expression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364, 725-729.
16. Dangain, J., and Vrbova, G. (1984). Muscle development in MDX mutant mice. Muscle Nerve 7, 700-704.
17. Deconinck, N., Ragot, T., Maréchal, G., Perricaudet, M., and Gillis, M. (1996). Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. USA 93, 3570-3574.
18. Deconinck, A.E., Potter, A.C., Tinsley, J.M., Wood, S.J., Vater, R., Young, C., Metzinger, L., Vincent, A., Slater, C.R., and Davies, K.E. (1997a). Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J. Cell Biol. 136, 883-894.
19. Deconinck, A.E., Rafael, J.A., Skinner, J.A., Brown, S.C., Potter, A.C., Metzinger, L., Watt, D.J., Dickson, J.G., Tinsley, J.M., and Davies, K.E. (1997b). Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell, in press, 90, 717-727.
20. DiMario, J.X., Uzman, A., and Strohman, R.C. (1991. Fiber regeneration is not persistent in dystrophic (MDX) mouse skeletal muscle. Dev. Biol. 148, 314-321.
21. Donoghue, M.J., Alvarez, J.D., Merlie, J.P., and Sanes, J.R. (1991). Fiber type-and position-dependent expression of a myosin light chain-CAT transgene detected with a novel histochemical stain for CAT. J. Cell Biol. 115, 423-434.
22. Engel, A.G. (1994). Acquired autoimmune myasthenia gravis. In Myology, A.G. Engel and C. Franzini-Armstrong, eds. (New York: McGraw-Hill, Inc.), pp. 1769-1797.
23. Engel, A.G., Yamamoto, M., and Fischbeck, K.H. (1994). Dystrophinopathies. In Myology, A.G. Engel and C. Franzini-Armstrong, eds. (New York: McGraw-Hill, Inc.), pp. 1133-1187.
24. Ervasti, J.M., and Campbell, K.P. (1993). A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809-823.
25. Frankel, K.A., and Rosser, R.J. (1976). The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum. Pathol. 7, 375-386.
26. Gautam, M., Noakes, P.G., Moscoso, L., Rupp, F., Scheller, R.H., Merlie, J.P., and Sanes, J.R. (1996). Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85, 525-535.
27. Gee, S.H., Montanaro, F., Lindenbaum, M.H., and Carbonetto, S. (1994). Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77, 675-686.
28. Gillis, J.M. (1996). Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: a review. Acta Physiol. Scand. 156, 397-406.
29. Grady, R.M., Merlie, J.P., and Sanes, J.R. (1997). Subtle neuromuscular defects in utrophin-deficient mice. J. Cell Biol. 136, 871-882.
30. Hoffman, E.P., Brown, R.H., and Kunkel, L.M. (1987). Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
31. Karpati, G., Carpenter, S., and Prescott, S. (1988). Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11, 795-803.
32. Karpati, G., Carpenter, S., Morris, G.E., Davies, K.E., Guerin, C., and Holland, P. (1993). Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J. Neuropathol. Exp. Neurol. 52, 119-128.
33. Khurana, T.S., Watkins, S.C., Chafey, P., Chelly, J., Tomé, F., Fardeau, M., Kaplan, J., and Kunkel, L.M. (1991). Immunolocalization and development expression of dystrophin related protein in skeletal muscle. Neuromusc. Disord. 1, 185-194.
34. Lichtman, J.W., and Wilkinson, R.S. (1987). Properties of motor units in the transversus abdominis muscle of the garter snake. J. Physiol. 393, 355-374.
35. Lyons, P.R., and Slater, C.R. (1991). Structure and function of the neuromuscular junction in young adult mdx mice. J. Neurocytol. 20, 969-981.
36. Mastaglia, F.L., Dawkins, R.L., and Papadimitriou, J.M. (1975). Morphological changes in skeletal muscle after transplantation. J. Neurol. Sci. 25, 227-247.
37. Matsuda, R., Nishikawa, A., and Tanaka, H. (1995). Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans Blue: evidence of apoptosis in dystrophin-deficient muscle. J. Biochem. 118, 959-964.
38. Matsumura, K., Ervasti, J.M., Ohlendieck, K., Kahl, S.D., and Campbell, K.P. (1992). Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360, 588-591.
39. McGeachie, J.K., Grounds, M.D., Partridge, T.A., and Morgan, J.E. (1993). Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies. J. Neurol. Sci. 119, 169-179.
40. Menke, A., and Jockusch, H. (1995). Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. J. Cell Sci. 108, 727-733.
41. Mora, M., DiBlasi, C., Barresi, R., Morandi, L., Brambati, B., Jarre, L., and Cornelio, F. (1996). Developmental expression of dystrophin, dystrophin-associated glycoproteins and other membrane cytoskeletal proteins in human skeletal and heart muscle. Dev. Brain Res. 91, 70-82.
42. Mukoyama, M., Kondo, K., Hizawa, K., Nishitani, H., and DMDR Group (1987). Life spans of Duchenne muscular dystrophy patients in the hospital care program in Japan. J. Neurol. Sci. 81, 155-158.
43. Nigro, G., Comi, L., Politano, L., and Bain, R.J.I. (1990). The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int. J. Cardiol. 26, 271-277.
44. Oda, T., Shimizu, N., Yonenobu, K., Ono, K., Nabeshima, T., and Kyo, S. (1993). Longitudinal study of spinal deformity in Duchenne muscular dystrophy. J. Pediatr. Orthop. 13, 478-488.
45. Ohlendieck, K., Ervasti, J.M., Matsumura, K., Kahl, S.O., Leveille, C.J., and Campbell, K.P. (1991). Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 7, 499-508.
46. Pasternak, C., Wong, S., and Elson, E.L. (1995). Mechanical function of dystrophin in muscle cells. J. Cell Biol. 128, 355-361.
47. Peters, M.F., Kramarcy, N.R., Sealock, R., and Froehner, S.C. (1994). β2-Syntrophin: localization at the neuromuscular junction in skeletal muscle. Neuroreport 5, 1577-1580.
48. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M., and Sweeney, H.L. (1993a). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710-3714.
49. Petrof, B.J., Stedman, H.H., Shrager, J.B., Eby, J., Sweeney, H.L., and Kelly, A.M. (1993b). Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. Am. J. Physiol. 265, C834-C841.
50. Pons, F., Augier, N., Leger, J.O., Robert, A., Tome, F.M., Fardeau, M., Voit, T., Nicholson, L.V., Mornet, D., and Leger, J.J. (1991). A homolog of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice. Immunological evidence. FEBS Lett. 282, 161-165.
51. Quinlivan, R.M., Lewis, P., Marsden, P., Dundas, R., Robb, S.A., Baker, E., and Maisey, M. (1996). Cardiac function, metabolism and perfusion in Duchenne and Becker muscular dystrophy. Neuromusc. Disord. 6, 237-246.
52. Reiser, P.J., Greaser, M.L., and Moss, R.L. (1988). Myosin heavy chain composition of single cells from avian slow skeletal muscle is strongly correlated with velocity of shortening during development. Dev. Biol. 129, 400-407.
53. Rezvani, M., Cafarelli, E., and Hood, D.A. (1995). Performance and excitability of mdx mouse muscle at 2, 5, and 13 wk of age. J. Appl. Physiol. 78, 961-967.
54. Sanes, J.R. (1995). The synaptic cleft of the neuromuscular junction. Dev. Biol. 6, 163-173.
55. Sartore, S., Gorza, L., and Schiaffino, S. (1982). Fetal myosin heavy chains in regenerating muscle. Nature 298, 294-296.
56. Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G., and Barnard, P.J. (1989). The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578-1579.
57. Stedman, H.H., Sweeney, H.L., Shrager, J.B., Maguire, H.C., Panettieri, R.A., Petrof, B., Narusawa, M., Leferovich, J.M., Sladky, J.T., and Kelly, A.M. (1991). The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536-538.
58. Sugiyama, J., Bowen, D.C.,and Hall, Z.W. (1994). Dystroglycan binds nerve and muscle agrin. Neuron 13, 103-115.
59. thiMan, N., Ellis, J.M., Love, D.R., Davies, K.E., Gatter, K.C., Dickson, G., and Morris, G.E. (1991). Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J. Cell Biol. 115, 1695-1700.
60. Tinsley, J.M., Potter, A.C., Phelps, S.R., Fisher, R., Trickett, J.I., and Davies, K.E. (1996). Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384, 349-353.
61. Torres, L.F.B., and Duchen, L.W. (1987). The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 110, 269-299.
62. Wakai, S., Minami, R., Kameda, K., Okabe, M., Nagaoka, M., Annaka, S., Higashidate, Y., Tomita, H., and Tachi, N. (1988). Electron microscopic study of the biopsied cardiac muscle in Duchenne muscular dystrophy. J. Neurol. Sci. 84, 167-175.
63. Wilkinson, R.S., Lunin, S.D., and Stevermer, J.J. (1992). Regulation of single quantal efficacy at the snake neuromuscular junction. J. Physiol. 448, 413-436.